name,category,termsATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,INTERPRO[450000213$IPR000245:ATPase, V0 complex, proteolipid subunit C, 450002116$IPR002379:ATPase, F0/V0 complex, subunit C]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,PIR_SUPERFAMILY[630001438$PIRSF001292:vacuolar H(+)-transporting ATPase 16K chain]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport, 790001602$Vacuole]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,UP_SEQ_FEATURE[850099777$chain:V-type proton ATPase 21 kDa proteolipid subunit, 850117295$sequence variant, 850118208$site:Essential for proton translocation, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
F-box and WD repeat domain containing 4,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
F-box and WD repeat domain containing 4,OMIM_DISEASE[520004643$Split hand/foot malformation (ectrodactyly) , type 3]
F-box and WD repeat domain containing 4,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
F-box and WD repeat domain containing 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001642$wnt signaling pathway]
F-box and WD repeat domain containing 4,UP_SEQ_FEATURE[850018850$chain:F-box/WD repeat-containing protein 4, 850103725$domain:F-box, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117294$sequence conflict]
POU class 2 homeobox 1,INTERPRO[450000280$IPR000327:POU-specific, 450000844$IPR000972:Octamer-binding transcription factor, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450016278$IPR017970:Homeobox, conserved site]
POU class 2 homeobox 1,OMIM_DISEASE[520004059$Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes]
POU class 2 homeobox 1,PIR_SUPERFAMILY[630002733$PIRSF002625:transcription factor Oct-1]
POU class 2 homeobox 1,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 2 homeobox 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
POU class 2 homeobox 1,UP_SEQ_FEATURE[850040236$chain:POU domain, class 2, transcription factor 1, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
T-cell activation RhoGTPase activating protein,INTERPRO[450000169$IPR000198:RhoGAP]
T-cell activation RhoGTPase activating protein,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
T-cell activation RhoGTPase activating protein,SMART[760000293$SM00324:RhoGAP]
T-cell activation RhoGTPase activating protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001212$polymorphism]
T-cell activation RhoGTPase activating protein,UP_SEQ_FEATURE[850063346$chain:T-cell activation Rho GTPase-activating protein, 850105183$domain:Rho-GAP, 850117295$sequence variant, 850118574$splice variant]
TSPY-like 2,INTERPRO[450001919$IPR002164:Nucleosome assembly protein (NAP)]
TSPY-like 2,SP_PIR_KEYWORDS[790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TSPY-like 2,UP_SEQ_FEATURE[850063916$chain:Testis-specific Y-encoded-like protein 2, 850102404$compositionally biased region:Arg-rich, 850102448$compositionally biased region:Asn-rich, 850102458$compositionally biased region:Asp-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
ankyrin repeat and sterile alpha motif domain containing 3,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450001870$IPR002110:Ankyrin, 450012380$IPR013761:Sterile alpha motif-type]
ankyrin repeat and sterile alpha motif domain containing 3,SMART[760000220$SM00248:ANK, 760000399$SM00454:SAM]
ankyrin repeat and sterile alpha motif domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat and sterile alpha motif domain containing 3,UP_SEQ_FEATURE[850005336$chain:Ankyrin repeat and SAM domain-containing protein 3, 850102597$compositionally biased region:Ser-rich, 850105249$domain:SAM, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
brain and reproductive organ-expressed (TNFRSF1A modulator),INTERPRO[450009421$IPR010358:Brain and reproductive organ-expressed]
brain and reproductive organ-expressed (TNFRSF1A modulator),PIR_SUPERFAMILY[630007027$PIRSF007150:anti-apoptotic protein BRE]
brain and reproductive organ-expressed (TNFRSF1A modulator),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001304$repeat]
brain and reproductive organ-expressed (TNFRSF1A modulator),UP_SEQ_FEATURE[850008344$chain:BRCA1-A complex subunit BRE, 850106258$modified residue, 850115008$region of interest:UEV-like 1, 850115009$region of interest:UEV-like 2, 850117294$sequence conflict, 850118574$splice variant]
cleavage and polyadenylation specific factor 7, 59kDa,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cleavage and polyadenylation specific factor 7, 59kDa,SMART[760000328$SM00360:RRM]
cleavage and polyadenylation specific factor 7, 59kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding]
cleavage and polyadenylation specific factor 7, 59kDa,UP_SEQ_FEATURE[850011676$chain:Cleavage and polyadenylation specificity factor subunit 7, 850102404$compositionally biased region:Arg-rich, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105211$domain:RRM, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007406$IPR008069:Cytochrome P450, E-class, group I, CYP2D-like, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,SP_PIR_KEYWORDS[790000652$heme, 790000802$iron, 790000937$metal-binding, 790000984$Monooxygenase, 790001092$oxidoreductase]
cytochrome P450, family 3, subfamily A, polypeptide 5,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 3, subfamily A, polypeptide 5,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450002135$IPR002402:Cytochrome P450, E-class, group II, 450002136$IPR002403:Cytochrome P450, E-class, group IV, 450007409$IPR008072:Cytochrome P450, E-class, CYP3A, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 3, subfamily A, polypeptide 5,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038781$hsa00591:Linoleic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
cytochrome P450, family 3, subfamily A, polypeptide 5,OMIM_DISEASE[520002484$Hypertension, salt-sensitive essential, susceptibility to]
cytochrome P450, family 3, subfamily A, polypeptide 5,PIR_SUPERFAMILY[630000064$PIRSF000051:cytochrome P450 CYP3A5]
cytochrome P450, family 3, subfamily A, polypeptide 5,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 3, subfamily A, polypeptide 5,UP_SEQ_FEATURE[850013779$chain:Cytochrome P450 3A5, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850117295$sequence variant]
glucose-fructose oxidoreductase domain containing 1,COG_ONTOLOGY[90000073$General function prediction only]
glucose-fructose oxidoreductase domain containing 1,INTERPRO[450000584$IPR000683:Oxidoreductase, N-terminal, 450003619$IPR004104:Oxidoreductase, C-terminal, 450014426$IPR016040:NAD(P)-binding domain]
glucose-fructose oxidoreductase domain containing 1,PIR_SUPERFAMILY[630004854$PIRSF004908:GFO/IDH/MocA oxidoreductases]
glucose-fructose oxidoreductase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
glucose-fructose oxidoreductase domain containing 1,UP_SEQ_FEATURE[850021482$chain:Glucose-fructose oxidoreductase domain- containing protein 1, 850117814$signal peptide, 850118574$splice variant]
katanin p60 (ATPase-containing) subunit A 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450013857$IPR015415:Vps4 oligomerisation, C-terminal]
katanin p60 (ATPase-containing) subunit A 1,SMART[760000335$SM00382:AAA]
katanin p60 (ATPase-containing) subunit A 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790000960$microtubule, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein]
katanin p60 (ATPase-containing) subunit A 1,UP_SEQ_FEATURE[850027067$chain:Katanin p60 ATPase-containing subunit A1, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112461$region of interest:Interaction with KATNB1, 850112540$region of interest:Interaction with microtubule, 850118574$splice variant]
polymerase (DNA directed), lambda,INTERPRO[450000379$IPR000445:Helix-hairpin-helix motif, 450001201$IPR001357:BRCT, 450001779$IPR002008:DNA-directed DNA polymerase, family X, beta-like, 450001820$IPR002054:DNA-directed DNA polymerase, family X, 450003148$IPR003583:Helix-hairpin-helix DNA-binding, class 1, 450009999$IPR010996:DNA-directed DNA polymerase, family X, beta-like, N-terminal, 450017216$IPR018944:DNA polymerase lambda, fingers domain, 450018073$IPR019843:DNA polymerase family X, binding site]
polymerase (DNA directed), lambda,KEGG_PATHWAY[470038822$hsa03410:Base excision repair, 470038826$hsa03450:Non-homologous end-joining]
polymerase (DNA directed), lambda,SMART[760000249$SM00278:HhH1, 760000263$SM00292:BRCT, 760000428$SM00483:POLXc]
polymerase (DNA directed), lambda,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000460$dna replication, 790000465$dna synthesis, 790000466$dna-binding, 790000467$dna-directed dna polymerase, 790000891$lyase, 790000906$manganese, 790000937$metal-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
polymerase (DNA directed), lambda,UP_SEQ_FEATURE[850000150$active site:Schiff-base intermediate with DNA, 850015665$chain:DNA polymerase lambda, 850103153$domain:BRCT, 850105852$helix, 850106173$metal ion-binding site:Manganese, 850106258$modified residue, 850106259$mutagenesis site, 850111452$region of interest:DNA binding, 850113197$region of interest:Involved in primer binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
potassium channel, subfamily K, member 7,INTERPRO[450002860$IPR003280:Potassium channel, two pore-domain, 450004866$IPR005408:Potassium channel, two pore-domain, TWIK, 450011743$IPR013099:Ion transport 2]
potassium channel, subfamily K, member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium channel, subfamily K, member 7,UP_SEQ_FEATURE[850040058$chain:Potassium channel subfamily K member 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850114080$region of interest:Pore-forming 1, 850114082$region of interest:Pore-forming 2, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
protein kinase D2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450014162$IPR015727:Protein kinase C mu-related, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
protein kinase D2,OMIM_DISEASE[520000061$A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia]
protein kinase D2,SMART[760000096$SM00109:C1, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
protein kinase D2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
protein kinase D2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059797$chain:Serine/threonine-protein kinase D2, 850104979$domain:PH, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118893$zinc finger region:Phorbol-ester/DAG-type 1, 850118894$zinc finger region:Phorbol-ester/DAG-type 2]
regulator of G-protein signaling 4,INTERPRO[450000294$IPR000342:Regulator of G protein signalling]
regulator of G-protein signaling 4,OMIM_DISEASE[520004400$Schizophrenia, susceptibility to]
regulator of G-protein signaling 4,PIR_SUPERFAMILY[630005694$PIRSF005770:regulator of G protein signaling, RGS4 type]
regulator of G-protein signaling 4,SMART[760000285$SM00315:RGS]
regulator of G-protein signaling 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000881$lipoprotein, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 4,UP_SEQ_FEATURE[850057033$chain:Regulator of G-protein signaling 4, 850105178$domain:RGS, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850117295$sequence variant]
serine peptidase inhibitor, Kunitz type 4,INTERPRO[450001971$IPR002223:Proteinase inhibitor I2, Kunitz metazoa]
serine peptidase inhibitor, Kunitz type 4,SMART[760000113$SM00131:KU]
serine peptidase inhibitor, Kunitz type 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790001212$polymorphism, 790001253$protease inhibitor, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
serine peptidase inhibitor, Kunitz type 4,UP_SEQ_FEATURE[850027629$chain:Kunitz-type protease inhibitor 4, 850102883$disulfide bond, 850103140$domain:BPTI/Kunitz inhibitor, 850117295$sequence variant, 850117814$signal peptide]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,BIOCARTA[30000178$h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001550$transit peptide, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,UP_SEQ_FEATURE[850066548$chain:Tricarboxylate transport protein, mitochondrial, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
solute carrier family 5 (sodium-dependent vitamin transporter), member 6,COG_ONTOLOGY[90000073$General function prediction only]
solute carrier family 5 (sodium-dependent vitamin transporter), member 6,INTERPRO[450001537$IPR001734:Sodium/solute symporter, 450016499$IPR018212:Sodium/solute symporter, conserved site, 450018129$IPR019900:Sodium/solute symporter, subgroup]
solute carrier family 5 (sodium-dependent vitamin transporter), member 6,SP_PIR_KEYWORDS[790000185$biotin, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
solute carrier family 5 (sodium-dependent vitamin transporter), member 6,UP_SEQ_FEATURE[850061225$chain:Sodium-dependent multivitamin transporter, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 5 (sodium/glucose cotransporter), member 11,INTERPRO[450001537$IPR001734:Sodium/solute symporter, 450016499$IPR018212:Sodium/solute symporter, conserved site, 450018129$IPR019900:Sodium/solute symporter, subgroup]
solute carrier family 5 (sodium/glucose cotransporter), member 11,PIR_SUPERFAMILY[630002894$PIRSF002803:proline carrier protein]
solute carrier family 5 (sodium/glucose cotransporter), member 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001457$sugar transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
solute carrier family 5 (sodium/glucose cotransporter), member 11,UP_SEQ_FEATURE[850061276$chain:Sodium/myo-inositol cotransporter 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vesicle-associated membrane protein 1 (synaptobrevin 1),INTERPRO[450001233$IPR001388:Synaptobrevin, 450014766$IPR016444:Synaptobrevin, metazoa/fungi]
vesicle-associated membrane protein 1 (synaptobrevin 1),KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
vesicle-associated membrane protein 1 (synaptobrevin 1),OMIM_DISEASE[520002056$Genome-wide association with bone mass and geometry in the Framingham Heart Study]
vesicle-associated membrane protein 1 (synaptobrevin 1),PIR_SUPERFAMILY[630005334$PIRSF005409:Synaptobrevin_euk]
vesicle-associated membrane protein 1 (synaptobrevin 1),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001162$phosphoprotein, 790001475$synapse, 790001477$Synaptosome, 790001555$transmembrane]
vesicle-associated membrane protein 1 (synaptobrevin 1),UP_SEQ_FEATURE[850100231$chain:Vesicle-associated membrane protein 1, 850105618$domain:v-SNARE coiled-coil homology, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
